Sinead Dullaghan

Sr. Principal Scientist TSMS at Eli Lilly

Speaker

Sinead received her Master’s level qualification in Biopharmaceutical Science in 2015. Sinead has 18 years of biotech experience across multiple roles in the industry. She joined Eli Lilly in 2010, where she has worked in a number of different functions across operations, management and TSMS. Sinead is currently a Sr. Principal Scientist in the upstream TSMS group. She was a key member in a number of new product introductions and was the cell culture lead for the most recent tech transfer which incorporated perfusion technology.